No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs636398 |
chr9:22680915-22680916 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs550488471 |
chr9:22680919-22680920 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs563921045 |
chr9:22680953-22680954 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs180865441 |
chr9:22680956-22680957 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs552739943 |
chr9:22680958-22680959 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs566180816 |
chr9:22680990-22680991 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs1448783 |
chr9:22680996-22680997 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs548572397 |
chr9:22680997-22680998 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs571073078 |
chr9:22681038-22681039 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs566981290 |
chr9:22681041-22681042 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs536191799 |
chr9:22681114-22681115 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs556016111 |
chr9:22681115-22681116 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs569547326 |
chr9:22681136-22681137 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs142642097 |
chr9:22681139-22681140 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs545056426 |
chr9:22681159-22681160 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs572107780 |
chr9:22681234-22681235 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs540731528 |
chr9:22681245-22681246 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs554593212 |
chr9:22681248-22681249 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs540009817 |
chr9:22681306-22681307 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs117849780 |
chr9:22681309-22681310 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs146917356 |
chr9:22681343-22681344 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs139340961 |
chr9:22681372-22681373 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs73446558 |
chr9:22681441-22681442 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs185466675 |
chr9:22681481-22681482 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs189883091 |
chr9:22681484-22681485 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs182205897 |
chr9:22681524-22681525 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs373341136 |
chr9:22681557-22681558 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs568142564 |
chr9:22681580-22681581 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs530797249 |
chr9:22681630-22681631 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs117993789 |
chr9:22681632-22681633 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs569633818 |
chr9:22681664-22681665 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs538495865 |
chr9:22681675-22681676 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs558722996 |
chr9:22681687-22681688 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541471447 |
chr9:22681703-22681704 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs35281415 |
chr9:22681723-22681724 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs565730402 |
chr9:22681742-22681743 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs534765841 |
chr9:22681773-22681774 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs622693 |
chr9:22681776-22681777 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs140736156 |
chr9:22681789-22681790 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs187295059 |
chr9:22681808-22681809 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs111288706 |
chr9:22681843-22681844 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs191681357 |
chr9:22681865-22681866 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs577615670 |
chr9:22681871-22681872 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs150080075 |
chr9:22681883-22681884 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs138477221 |
chr9:22681907-22681908 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs537852877 |
chr9:22681913-22681914 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs528655405 |
chr9:22681973-22681974 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs113436654 |
chr9:22681977-22681978 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs561860655 |
chr9:22681978-22681979 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs4977792 |
chr9:22681982-22681983 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|